Bone Marrow Transplant Clinical Trials

7 recruiting

Bone Marrow Transplant Trials at a Glance

20 actively recruiting trials for bone marrow transplant are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Boston, Philadelphia, and Birmingham. Lead sponsors running bone marrow transplant studies include Massachusetts General Hospital, Investigator driven study, and Institute of Hematology & Blood Diseases Hospital, China.

Browse bone marrow transplant trials by phase

Treatments under study

About Bone Marrow Transplant Clinical Trials

Looking for clinical trials for Bone Marrow Transplant? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bone Marrow Transplant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bone Marrow Transplant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Not Applicable

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

Sexual DysfunctionStem Cell Transplant ComplicationsBone Marrow Transplant Complications
Massachusetts General Hospital300 enrolled3 locationsNCT06541002
Recruiting
Phase 2

Orphan Indications for CD19 Redirected Autologous T Cells

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALLPatients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation
Stephan Grupp MD PhD133 enrolled1 locationNCT04276870
Recruiting
Not Applicable

Rehab Study for alloBMT Patients

Allogenic Bone Marrow Transplantation
Jennifer Jones208 enrolled1 locationNCT07457866
Recruiting
Not Applicable

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

Bone Marrow Transplant Complications
Massachusetts General Hospital350 enrolled2 locationsNCT06910969
Recruiting

National Longitudinal Cohort of Hematological Diseases

Acute Myeloid LeukemiaMultiple MyelomaMyelodysplastic Syndrome+14 more
Institute of Hematology & Blood Diseases Hospital, China2,300 enrolled1 locationNCT04645199
Recruiting
Phase 2

Shingrix In Recipients of Allogeneic Transplants

Bone Marrow TransplantStem Cell Transplant
University of Colorado, Denver55 enrolled1 locationNCT05775718
Recruiting

Activity Levels in Bone Marrow Transplant Patients

Bone Marrow Transplant
Michael Tomasson200 enrolled1 locationNCT04115241
Recruiting
Not Applicable

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

Hematologic MalignancyBone Marrow Transplant Complications
Massachusetts General Hospital800 enrolled3 locationsNCT06472089
Recruiting

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

Multiple MyelomaMyelodysplastic SyndromeLymphoma+12 more
Yigeng Cao,MD,PhD1,000 enrolled1 locationNCT07205523
Recruiting
Early Phase 1

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Multiple MyelomaLymphomaHematologic Malignancy+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8 enrolled1 locationNCT06398457
Recruiting

HPC Offered for PRESERVE Expansion

Bone Marrow Transplant (BMT)
Ossium Health, Inc.10 enrolled4 locationsNCT07145411
Recruiting

Cardiovascular Risk in Children With Chronic Conditions Study

Obesity and OverweightLymphomaLeukemia+13 more
Semmelweis University300 enrolled3 locationsNCT07086989
Recruiting
Not Applicable

Mosaic Trial for Stem Cell Transplant Recipients

Multiple MyelomaLymphomaLeukemia+4 more
Northwestern University356 enrolled3 locationsNCT06960993
Recruiting
Not Applicable

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC)

NeoplasmsBone Marrow Transplantation
Murdoch Childrens Research Institute880 enrolled4 locationsNCT05667766
Recruiting

Genetics in the Progression of Nephropathies

HypertensionHematologic MalignancyCKD+5 more
Ospedale San Raffaele10,000 enrolled1 locationNCT06416761
Recruiting

Rehabilitation after bone marrow transplant- what is the impact on patient outcomes? The REBOOT trial

MalignancyBone Marrow Transplant
University of Melbourne170 enrolled3 locationsACTRN12622001071718
Recruiting

COVID-19 Vaccine Efficacy in patients with Blood Cancer

COVID-19Bone Marrow TransplantHaematological Malignancy
Royal Brisbane and Women's Hospital50 enrolled1 locationACTRN12621000538842
Recruiting
Phase 2Phase 3

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Bone Marrow Transplant Complications
Hospital Israelita Albert Einstein50 enrolled1 locationNCT03818334
Recruiting

The immunogenicity of 7-valent pneumococcal conjugate vaccine (PCV-7) in allogeneic bone marrow transplant recipients

Patient is scheduled to have allogeneic bone marrow transplantation (mathced realted or unrealted) excluding cord transplant.
Investigator driven study30 enrolled1 locationACTRN12605000773639
Recruiting

HPV infection and cervial dysplasia in bone marrow transplant recipients

Bone Marrow Transplant
Melbourne Health82 enrolled1 locationACTRN12605000645651